Adverum Biotechnologies (ADVM) PT Lowered to $4.50 at Chardan Capital Markets
Chardan Capital Markets analyst Gbola ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
